文献速递精神分裂症与精神病性障碍

精神分裂症谱系障碍的多元模型:超越多巴胺

Toward a Pluralistic Model for the Schizophrenia Spectrum-Dopamine and Beyond.
PubMed 文献 · JAMA Psychiatry · 2026-01-01

本文综述1980至2025年神经影像、遗传、药理学和临床试验证据,认为多巴胺能失调并非精神分裂症谱系障碍所有症状领域的通用最终通路,提出应采纳涵盖多种神经化学与细胞过程的多元模型,以解释异质性和治疗抵抗。

要点

  • 阳性精神病性症状与联想纹状体突触前多巴胺活性增高相关,可预测D2受体拮抗剂反应。
  • 约三分之一患者治疗抵抗且纹状体多巴胺合成能力无增高,提示非多巴胺机制参与。
  • 毒蕈碱M1/M4激动剂xanomeline-trospium有效,支持非多巴胺机制可减轻精神病性症状。

核心结论

  • 多巴胺能亢进可能是许多患者核心精神病性症状的关键机制,但不太可能是跨症状领域的通用最终通路。
  • 多元模型承认多种相互作用的神经化学和细胞过程,可能更好地解释异质性和转化失败。

研究设计与样本

  • 证据综述综合了1980至2025年发表的神经影像、尸检、遗传、药理挑战范式、临床试验和动物模型研究。
  • 通过专家知识和PubMed及相关数据库的针对性检索识别研究,强调系统综述、荟萃分析和多模态汇聚发现。
  • 证据采用定性评估,关注一致性、特异性和转化相关性。

主要发现

  • 阳性精神病性症状与联想纹状体突触前多巴胺活性增高强烈相关,可预测对多巴胺D2受体拮抗剂的反应。
  • 约三分之一患者表现出治疗抵抗,且纹状体多巴胺合成能力无增高。
  • 越来越多证据涉及谷氨酸能、γ-氨基丁酸(GABA)能、5-羟色胺能、胆碱能、内源性大麻素和阿片系统,以及氧化应激、线粒体功能障碍和神经炎症等非神经递质过程。
  • 缺乏直接D2受体拮抗作用的毒蕈碱M1/M4偏好激动剂xanomeline-trospium有效,表明非多巴胺机制可减轻精神病性症状。
  • 精神分裂症谱系障碍内神经化学上不同的亚组可能跨越重叠的临床表型。

关键数值与推荐

  • 阳性精神病性症状与联想纹状体突触前多巴胺活性增高相关,预测D2受体拮抗剂反应。
  • 约三分之一患者治疗抵抗且纹状体多巴胺合成能力无增高。
  • xanomeline-trospium(毒蕈碱M1/M4偏好激动剂,无直接D2受体拮抗)可减轻精神病性症状。

临床怎么用

  • 临床应认识到多巴胺亢进并非所有精神分裂症谱系障碍患者的通用机制,尤其治疗抵抗者。
  • 未来治疗开发可能依赖生物标志物指导的分层、基于机制的临床试验以及分子、环路和临床表型的整合。

局限性

  • 证据定性评估,未报告系统评价的定量合并或偏倚风险评估。
  • 检索策略基于专家知识和针对性搜索,可能未全面覆盖所有相关研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Dopaminergic dysregulation has been considered the final common pathway for pathophysiology of schizophrenia and related disorders (SRD). However, this model does not adequately explain treatment resistance, cognitive impairment, negative symptoms, and marked biological heterogeneity across patients. OBJECTIVE: To examine whether SRD are best conceptualized as resulting from a final common dopaminergic pathway or from several partially independent neurochemical mechanisms and to evaluate the implications of these models for treatment development. EVIDENCE REVIEW: Neuroimaging, postmortem and genetic investigations, pharmacologic challenge paradigms, clinical trials, and animal models published between 1980 and 2025 were synthesized. Studies were identified through expert knowledge and targeted searches of PubMed and related databases. Systematic reviews, meta-analyses, and multimodal convergent findings were emphasized. Evidence was appraised qualitatively with attention to consistency, specificity, and translational relevance. FINDINGS: Positive psychotic symptoms are strongly linked to increased presynaptic dopaminergic activity in the associative striatum, which predicts response to dopamine D2 receptor antagonists. However, approximately one-third of patients exhibit treatment resistance and show no increase in striatal dopamine synthesis capacity. Increasing evidence implicates glutamatergic, gamma-aminobutyric acid (GABA)ergic, serotonergic, cholinergic, endocannabinoid, and opioidergic systems, as well as nonneurotransmitter processes including oxidative stress, mitochondrial dysfunction, and neuroinflammation. The efficacy of the muscarinic M1/M4-preferring agonist xanomeline-trospium, which lacks direct D2 receptor antagonism, suggests that nondopaminergic mechanisms can reduce psychotic symptoms. Neurochemically distinct subgroups within SRD may cut across overlapping clinical phenotypes. CONCLUSIONS AND RELEVANCE: Dopaminergic hyperactivity may be a key mechanism for core psychotic symptoms in many patients, but it is unlikely that dopamine dysregulation is a universal final common pathway across symptom domains. A pluralistic model-recognizing multiple interacting neurochemical and cellular processes-may better account for heterogeneity and translational failures. Future development of novel treatments may depend on biomarker-informed stratification, mechanism-based clinical trials, and integration of molecular, circuit-level, and clinical phenotypes.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Keshavan MS, Nasrallah HA, Abi-Dargham A, et al. Toward a Pluralistic Model for the Schizophrenia Spectrum-Dopamine and Beyond. JAMA Psychiatry. 2026. PMID: 42418174. doi:10.1001/jamapsychiatry.2026.1684

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。